FI991485A0 - Ny farmaceutisk komposition - Google Patents
Ny farmaceutisk kompositionInfo
- Publication number
- FI991485A0 FI991485A0 FI991485A FI991485A FI991485A0 FI 991485 A0 FI991485 A0 FI 991485A0 FI 991485 A FI991485 A FI 991485A FI 991485 A FI991485 A FI 991485A FI 991485 A0 FI991485 A0 FI 991485A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical composition
- new pharmaceutical
- new
- composition
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (47)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI991485A FI109453B (sv) | 1999-06-30 | 1999-06-30 | Farmaceutisk komposition |
TW089110218A TWI241187B (en) | 1999-06-30 | 2000-05-26 | Levodopa/carbidopa/entacapone pharmaceutical composition |
PE2000000641A PE20010399A1 (es) | 1999-06-30 | 2000-06-27 | Composicion solida oral que contiene entacapona, levodopa y carbidopa |
IT2000MI001450A ITMI20001450A1 (it) | 1999-06-30 | 2000-06-28 | Nuova composizione farmaceutica |
CO00048944A CO5180579A1 (es) | 1999-06-30 | 2000-06-29 | Composicion oral solida que comprende levidopa, carbidopa y entacapone |
BRPI0011867A BRPI0011867B8 (pt) | 1999-06-30 | 2000-06-29 | preparação farmacêutica de levodopa/carbidopa/entacapona e processo para preparação da mesma |
CZ20014636A CZ303010B6 (cs) | 1999-06-30 | 2000-06-29 | Perorální pevná kompozice obsahující entacapon, levodopu a karbidopu, zpusoby její prípravy a použití |
EA200200106A EA004503B1 (ru) | 1999-06-30 | 2000-06-29 | Фармацевтическая композиция леводопа/карбидопа/энтакапон |
US09/605,529 US6500867B1 (en) | 1999-06-30 | 2000-06-29 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
YUP-925/01A RS50368B (sr) | 1999-06-30 | 2000-06-29 | Levodopa/karbidopa/entakapon farmaceutski preparat |
AU58306/00A AU765932B2 (en) | 1999-06-30 | 2000-06-29 | Levodopa / carbidopa / entacapone pharmaceutical preparation |
EP00944070A EP1189608B1 (en) | 1999-06-30 | 2000-06-29 | Levodopa/carbidopa/entacapone pharmaceutical preparation |
ES00944070T ES2203495T3 (es) | 1999-06-30 | 2000-06-29 | Preparado farmaceutico de levodopa/carbidopa/entacapona. |
DE60004052T DE60004052T2 (de) | 1999-06-30 | 2000-06-29 | Pharmazeutische zubereitungen auf der basis von levodopa, carbidopa und entacapone |
UA2002010771A UA75047C2 (en) | 1999-06-30 | 2000-06-29 | Fixed dose composition of levodopa, carbidopa and entacapone |
BR0011867-2A BR0011867A (pt) | 1999-06-30 | 2000-06-29 | Preparação farmacêutica de levodopa/carbidopa/entacapona |
MYPI20002972A MY127685A (en) | 1999-06-30 | 2000-06-29 | Levodopa/carbidopa/entacapone pharmaceutical preparation |
CA002378469A CA2378469C (en) | 1999-06-30 | 2000-06-29 | An oral solid composition comprising carbidopa, levodopa and entacapone |
GE4619A GEP20043314B (en) | 1999-06-30 | 2000-06-29 | Pharmaceutical Composition Comprising Entacapone, Levodopa, and Carbidopa |
TR2001/03763T TR200103763T2 (tr) | 1999-06-30 | 2000-06-29 | Levodopa/karbidopa/entakapon farmasötik preparasyonu. |
NZ515780A NZ515780A (en) | 1999-06-30 | 2000-06-29 | Levodopa / carbidopa / entacapone pharmaceutical preparation |
CNB008095868A CN1168440C (zh) | 1999-06-30 | 2000-06-29 | 左旋多巴/卡比多巴/恩他卡朋药物制剂 |
KR1020017015737A KR100905428B1 (ko) | 1999-06-30 | 2000-06-29 | 레보도파/카비도파/엔타카폰 약학적 제제 |
MXPA01013167A MXPA01013167A (es) | 1999-06-30 | 2000-06-29 | Preparacion farmaceutica de levodopa / carbidopa / entacapona. |
PL352775A PL197818B1 (pl) | 1999-06-30 | 2000-06-29 | Stałe doustne kompozycje lewodopa/karbidopa/entakapon, sposób ich wytwarzania oraz ich zastosowanie |
JP2001507476A JP4204783B2 (ja) | 1999-06-30 | 2000-06-29 | レボドパ/カルビドパ/エンタカポン医薬製剤 |
MEP-2008-863A ME00520B (me) | 1999-06-30 | 2000-06-29 | Levodop/karbidop/entakapon farmaceutski preparat |
AT00944070T ATE245417T1 (de) | 1999-06-30 | 2000-06-29 | Pharmazeutische zubereitungen auf der basis von levodopa, carbidopa und entacapone |
SI200030190T SI1189608T1 (en) | 1999-06-30 | 2000-06-29 | Levodopa/carbidopa/entacapone pharmaceutical preparation |
DK00944070T DK1189608T3 (da) | 1999-06-30 | 2000-06-29 | Farmaceutisk fremstilling på basis af levodopa, carbidopa og entacapon |
ARP000103325A AR033796A1 (es) | 1999-06-30 | 2000-06-29 | Composicion farmaceutica |
PT00944070T PT1189608E (pt) | 1999-06-30 | 2000-06-29 | Preparacao farmaceutica de levodopa/carbidopa/entacapona |
CZ2011-885A CZ304416B6 (cs) | 1999-06-30 | 2000-06-29 | Farmaceutická kompozice obsahující entacapon, levodopu a karbidopu a léčivo pro léčení Parkinsonovy choroby |
HU0202273A HU230395B1 (hu) | 1999-06-30 | 2000-06-29 | Levodopa /carbidopa/ entacapone tartalmú orálisan adagolható szilárd készítmény, eljárás ennek előállítására és ezt tartalmazó tabletta |
EEP200100716A EE05473B1 (et) | 1999-06-30 | 2000-06-29 | Levodopa/karbidopa/entakapooni farmatseutiline preparaat, selle valmistamise meetod ja kasutamine |
SK1923-2001A SK286451B6 (sk) | 1999-06-30 | 2000-06-29 | Perorálna pevná kompozícia obsahujúca entakapon, levodopu a karbidopu a spôsoby jej prípravy a použitie |
PCT/FI2000/000593 WO2001001984A1 (en) | 1999-06-30 | 2000-06-29 | Levodopa / carbidopa / entacapone pharmaceutical preparation |
FR0008472A FR2797587A1 (fr) | 1999-06-30 | 2000-06-30 | Nouvelle composition pharmaceutique |
ZA200109868A ZA200109868B (en) | 1999-06-30 | 2001-11-29 | Levodopa/carbidopa/entacapone pharmaceutical preparation. |
IL146807A IL146807A (en) | 1999-06-30 | 2001-11-29 | Preparation of pharmaceutical preparations of Lavadopa / Carbidopa / Antacapone |
NO20016203A NO330260B1 (no) | 1999-06-30 | 2001-12-18 | Oral, fast sammensetning omfattende levodopa/carbidopa/entacapon, fremgangsmate for fremstilling derav, samt anvendelse av en sammensetning omfattende levodopa/carbidopa/entacapon for fremstilling av et medikament til behandling av Parkinsons sykdom. |
BG106251A BG65364B1 (bg) | 1999-06-30 | 2001-12-20 | Фармацевтичен препарат леводопа/карбидопа/ентакапон |
HR20020088A HRP20020088B1 (en) | 1999-06-30 | 2002-01-29 | Levodopa/carbidopa/entacapone pharmaceutical preparation |
US10/223,298 US6797732B2 (en) | 1999-06-30 | 2002-08-20 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
HK02108609.4A HK1047040B (zh) | 1999-06-30 | 2002-11-29 | 左旋多巴/卡比多巴/恩他卡朋藥物製劑 |
JP2008063280A JP4885896B2 (ja) | 1999-06-30 | 2008-03-12 | レボドパ/カルビドパ/エンタカポン医薬製剤 |
NO20110090A NO20110090L (no) | 1999-06-30 | 2011-01-19 | Stabil fast oral sammensetning omfattende levodopa, carbidopa, og entacapon |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI991485A FI109453B (sv) | 1999-06-30 | 1999-06-30 | Farmaceutisk komposition |
FI991485 | 1999-06-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI991485A0 true FI991485A0 (sv) | 1999-06-30 |
FI991485A FI991485A (sv) | 2000-12-31 |
FI109453B FI109453B (sv) | 2002-08-15 |
Family
ID=8554988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI991485A FI109453B (sv) | 1999-06-30 | 1999-06-30 | Farmaceutisk komposition |
Country Status (42)
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI109453B (sv) * | 1999-06-30 | 2002-08-15 | Orion Yhtymae Oyj | Farmaceutisk komposition |
US20040166159A1 (en) * | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
US20030224045A1 (en) * | 2002-05-29 | 2003-12-04 | Chien-Hsuan Han | Combination immediate release sustained release levodopa/carbidopa dosage forms |
US20050147670A1 (en) * | 2002-05-29 | 2005-07-07 | Impax Laboratories Inc. | Oral disintegrating dosage forms |
US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
US20040006072A1 (en) * | 2002-06-25 | 2004-01-08 | Franz Robert M. | Sustained-release alprazolam composition |
US20040180086A1 (en) * | 2002-10-11 | 2004-09-16 | Zebunnissa Ramtoola | Gastro-retentive levodopa delivery form |
AR044007A1 (es) | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | Metodos para el tratamiento de la enfermedad de parkinson |
EP1588704A1 (en) | 2004-04-22 | 2005-10-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
SE0401842D0 (sv) * | 2004-07-12 | 2004-07-12 | Dizlin Medical Design Ab | Infusion and injection solution of levodopa |
WO2006037061A2 (en) * | 2004-09-28 | 2006-04-06 | Farouk Karoum | Compositions and methods of using d-dopa to treat parkinson's disease |
EP1812070B1 (en) | 2004-11-10 | 2013-10-02 | Orion Corporation | Treatment of restless legs syndrome |
AU2012216377C1 (en) * | 2005-06-08 | 2013-10-10 | Orion Corporation | Oral dosage form |
EA013161B1 (ru) * | 2005-06-08 | 2010-02-26 | Орион Корпорейшн | Дозированная форма для перорального применения |
US20070003621A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Dosage forms for movement disorder treatment |
MY148644A (en) | 2005-07-18 | 2013-05-15 | Orion Corp | New pharmaceutical compounds |
AU2006272978B2 (en) | 2005-07-26 | 2012-06-07 | Bial - Portela & Ca, S.A. | Nitrocatechol derivatives as COMT inhibitors |
WO2007016190A2 (en) * | 2005-07-28 | 2007-02-08 | Duke University | Antiparkinsonian action of phenylisopropylamines |
WO2007034024A2 (en) * | 2005-09-21 | 2007-03-29 | Orion Corporation | Treatment of symptoms of parkinson' s disease |
WO2007056570A2 (en) * | 2005-11-07 | 2007-05-18 | Teva Pharmaceutical Industries Ltd. | Levodopa compositions |
EP1954256A2 (en) * | 2005-11-09 | 2008-08-13 | Torrent Pharmaceuticals Ltd | Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent |
GB2429645A (en) * | 2006-03-10 | 2007-03-07 | Sekhsaria Chemicals Ltd | Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent |
CN100384411C (zh) * | 2006-03-17 | 2008-04-30 | 北京科信必成医药科技发展有限公司 | 卡左双多巴口腔崩解片 |
WO2007113371A1 (en) * | 2006-03-31 | 2007-10-11 | Iprbox Oy | Pharmaceutical composition and preparation method thereof |
EP1845097A1 (en) | 2006-04-10 | 2007-10-17 | Portela & Ca., S.A. | Oxadiazole derivatives as COMT inhibitors |
EP1870097A1 (en) * | 2006-06-15 | 2007-12-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders |
US8106056B2 (en) * | 2006-06-16 | 2012-01-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising bifeprunox and a dopamine agonist |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
EP2104424A4 (en) | 2006-10-30 | 2011-06-15 | Wockhardt Research Center | PHARMACEUTICAL COMPOSITIONS COMPRISING ENTACAPONE, LEVODOPA, AND CARBIDOPA |
AU2007338631A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
US20100104634A1 (en) * | 2006-12-27 | 2010-04-29 | Mahesh Rameshwar Kalantri | Pharmaceutical compositions of entacapone |
EP1946756A1 (en) * | 2007-01-17 | 2008-07-23 | Revotar Biopharmaceuticals AG | Use of entacapone in cosmetic, dermatological and pharmaceutical compositions |
DK2481410T3 (en) | 2007-01-31 | 2016-10-24 | Bial - Portela & Ca S A | Nitrocatecholderivater as COMT inhibitors administered in a specific dosage regimen |
US20110171275A1 (en) * | 2007-08-20 | 2011-07-14 | Team Academy Of Pharmaceutical Science | Gastroretentive drug delivery system, preparation method and use thereof |
AU2009211030B2 (en) * | 2008-02-06 | 2013-12-05 | Wockhardt Research Centre | Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
RU2485947C2 (ru) | 2008-02-06 | 2013-06-27 | Вокхардт Рисерч Сентер | Фармацевтические композиции энтакапона, леводопы и карбидопы с улучшенной биодоступностью |
MX2010009610A (es) | 2008-03-17 | 2010-09-30 | Bial Portela & Ca Sa | Formas de cristal de 5-[3-(2,5-dicloro-4,6-dimetil-1-oxi-piridin-3 -il)-[1,2,4]oxadiazol-5-il]-3-nitrobenceno-1,2-diol. |
AU2009283813B2 (en) * | 2008-08-22 | 2015-02-19 | Wockhardt Research Centre | An extended release pharmaceutical composition of entacapone or salts thereof |
CA2735050C (en) * | 2008-08-22 | 2016-07-26 | Wockhardt Research Centre | Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
TR200806646A2 (tr) * | 2008-09-03 | 2009-06-22 | Dr. F. Fri̇k İlaç San. Ve Ti̇c. A.Ş. | Entakapon, levodopa ve karbidoba içeren farmasötik kombinasyonlar |
EP2233131A1 (en) | 2009-03-23 | 2010-09-29 | Laboratorios Lesvi, S.L. | Pharmaceutical composition containing levodopa, entacapone and carbidopa |
WO2010114404A1 (en) | 2009-04-01 | 2010-10-07 | Bial - Portela & Ca., S.A. | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof |
JP5643297B2 (ja) * | 2009-05-19 | 2014-12-17 | ニューロデルム リミテッド | ドーパデカルボキシラーゼ阻害剤の連続投与のための組成物 |
WO2011075912A1 (zh) | 2009-12-25 | 2011-06-30 | 台湾东洋药品工业股份有限公司 | 治疗帕金森氏症的医药组合物及其制备方法 |
EP2542220B1 (en) * | 2010-03-04 | 2016-11-02 | Orion Corporation | Use of levodopa, carbidopa and entacapone for treating parkinson's disease |
DE102010023828A1 (de) | 2010-06-15 | 2011-12-15 | IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH | Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält |
ES2660772T3 (es) * | 2010-11-15 | 2018-03-26 | Neuroderm Ltd | Administración continua de L-dopa, inhibidores de dopa descarboxilasa, inhibidores de catecol-o-metil transferasa y composiciones para ello |
US20140045900A1 (en) | 2011-02-11 | 2014-02-13 | Bial-Portela & Ca, S.A. | Administration regime for nitrocatechols |
EP2508174A1 (en) | 2011-04-06 | 2012-10-10 | Ljiljana Sovic Brkicic | Pharmaceutical composition |
WO2012147099A1 (en) | 2011-04-25 | 2012-11-01 | Suven Nishtaa Pharma Pvt. Ltd. | Pharmaceutical compositions of levodopa, carbidopa and entacapone |
KR101807907B1 (ko) * | 2011-04-26 | 2017-12-11 | 이노파막스, 인크. | 엔타카폰의 조성물 |
JP6456143B2 (ja) | 2011-12-13 | 2019-01-23 | ノヴィファーマ,エス.アー. | カテコール−o−メチル転移酵素阻害剤を調製するための中間体として有用な化学的化合物 |
TR201204839A2 (tr) | 2012-04-25 | 2012-12-21 | Ali̇ Rai̇f İlaç Sanayi̇ A.Ş. | Uzatılmış salım sağlayan levodopa karbıdopa entakapon içeren tablet formülasyonu. |
CN107693486A (zh) | 2012-06-05 | 2018-02-16 | 纽罗德姆有限公司 | 包含阿朴吗啡和有机酸的组合物及其用途 |
JP6472391B2 (ja) * | 2013-03-13 | 2019-02-20 | ニューロダーム リミテッドNeuroderm Ltd | パーキンソン病の治療方法 |
EP2799065A1 (en) * | 2013-04-30 | 2014-11-05 | Deva Holding Anonim Sirketi | Levodopa carbidopa entacapone pharmaceutical formulations |
CN105658211A (zh) | 2013-10-07 | 2016-06-08 | 怡百克制药公司 | 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途 |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
EP3777833B1 (en) | 2014-03-13 | 2023-10-18 | Neuroderm Ltd. | Dopa decarboxylase inhibitor compositions |
US10258585B2 (en) | 2014-03-13 | 2019-04-16 | Neuroderm, Ltd. | DOPA decarboxylase inhibitor compositions |
EP3188725B1 (en) * | 2014-09-04 | 2020-10-28 | Lobsor Pharmaceuticals Aktiebolag | Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a comt inhibitor and method of administration thereof |
RU2017120184A (ru) | 2014-11-28 | 2018-12-28 | БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. | Лекарства для замедления течения болезни паркинсона |
EP3236957A1 (en) | 2014-12-23 | 2017-11-01 | Pharmathen S.A. | Levodopa/carbidopa/entacapone pharmaceutical preparation and method for preparing the same |
US10555922B2 (en) | 2015-09-04 | 2020-02-11 | Lobsor Pharmaceuticals Aktiebolag | Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor |
US11975104B2 (en) * | 2016-07-11 | 2024-05-07 | Contera Pharma A/S | Pulsatile drug delivery system for treating morning akinesia |
EP3500246B1 (en) | 2016-08-18 | 2021-08-04 | Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi | Antiparkinson tablet formulation with improved dissolution profile |
WO2019145773A1 (en) | 2017-12-15 | 2019-08-01 | Nos Life Sciences Corporation | Liposomal-encapsulated formulations |
AU2019237857A1 (en) | 2018-03-23 | 2020-10-08 | Lobsor Pharmaceuticals Aktiebolag | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders |
US11213502B1 (en) | 2020-11-17 | 2022-01-04 | Neuroderm, Ltd. | Method for treatment of parkinson's disease |
US11331293B1 (en) | 2020-11-17 | 2022-05-17 | Neuroderm, Ltd. | Method for treatment of Parkinson's disease |
US11844754B2 (en) | 2020-11-17 | 2023-12-19 | Neuroderm, Ltd. | Methods for treatment of Parkinson's disease |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4190672A (en) | 1978-09-01 | 1980-02-26 | Stanley Fahn | Method and compositions of treating Parkinsonisms with levodopa and 3',4'-dihydroxy-2-methylisopropiophenone |
GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
US5236952A (en) | 1986-03-11 | 1993-08-17 | Hoffmann-La Roche Inc. | Catechol derivatives |
NZ220599A (en) * | 1986-06-16 | 1990-10-26 | Merck & Co Inc | Controlled release oral dosage formulation of carbidopa and levodopa |
US5283352A (en) | 1986-11-28 | 1994-02-01 | Orion-Yhtyma Oy | Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same |
DE4101873C2 (de) | 1991-01-23 | 1993-12-09 | Isis Pharma Gmbh | Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände |
US5888534A (en) | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
GB2321190B (en) * | 1997-01-16 | 2000-09-20 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition |
US6599530B2 (en) | 1998-09-14 | 2003-07-29 | Orion Corporation | Oral compacted composition comprising catechol derivatives |
FI109453B (sv) | 1999-06-30 | 2002-08-15 | Orion Yhtymae Oyj | Farmaceutisk komposition |
-
1999
- 1999-06-30 FI FI991485A patent/FI109453B/sv not_active IP Right Cessation
-
2000
- 2000-05-26 TW TW089110218A patent/TWI241187B/zh not_active IP Right Cessation
- 2000-06-27 PE PE2000000641A patent/PE20010399A1/es not_active IP Right Cessation
- 2000-06-28 IT IT2000MI001450A patent/ITMI20001450A1/it unknown
- 2000-06-29 EP EP00944070A patent/EP1189608B1/en not_active Expired - Lifetime
- 2000-06-29 RS YUP-925/01A patent/RS50368B/sr unknown
- 2000-06-29 SI SI200030190T patent/SI1189608T1/xx unknown
- 2000-06-29 EA EA200200106A patent/EA004503B1/ru not_active IP Right Cessation
- 2000-06-29 AR ARP000103325A patent/AR033796A1/es unknown
- 2000-06-29 PL PL352775A patent/PL197818B1/pl unknown
- 2000-06-29 SK SK1923-2001A patent/SK286451B6/sk not_active IP Right Cessation
- 2000-06-29 MY MYPI20002972A patent/MY127685A/en unknown
- 2000-06-29 UA UA2002010771A patent/UA75047C2/uk unknown
- 2000-06-29 BR BR0011867-2A patent/BR0011867A/pt not_active IP Right Cessation
- 2000-06-29 AT AT00944070T patent/ATE245417T1/de active
- 2000-06-29 CO CO00048944A patent/CO5180579A1/es active IP Right Grant
- 2000-06-29 ME MEP-2008-863A patent/ME00520B/me unknown
- 2000-06-29 US US09/605,529 patent/US6500867B1/en not_active Expired - Lifetime
- 2000-06-29 CN CNB008095868A patent/CN1168440C/zh not_active Expired - Lifetime
- 2000-06-29 PT PT00944070T patent/PT1189608E/pt unknown
- 2000-06-29 AU AU58306/00A patent/AU765932B2/en not_active Expired
- 2000-06-29 WO PCT/FI2000/000593 patent/WO2001001984A1/en active Application Filing
- 2000-06-29 TR TR2001/03763T patent/TR200103763T2/xx unknown
- 2000-06-29 DK DK00944070T patent/DK1189608T3/da active
- 2000-06-29 ES ES00944070T patent/ES2203495T3/es not_active Expired - Lifetime
- 2000-06-29 JP JP2001507476A patent/JP4204783B2/ja not_active Expired - Lifetime
- 2000-06-29 GE GE4619A patent/GEP20043314B/en unknown
- 2000-06-29 CZ CZ2011-885A patent/CZ304416B6/cs not_active IP Right Cessation
- 2000-06-29 HU HU0202273A patent/HU230395B1/hu unknown
- 2000-06-29 NZ NZ515780A patent/NZ515780A/en not_active IP Right Cessation
- 2000-06-29 MX MXPA01013167A patent/MXPA01013167A/es active IP Right Grant
- 2000-06-29 EE EEP200100716A patent/EE05473B1/xx unknown
- 2000-06-29 KR KR1020017015737A patent/KR100905428B1/ko active IP Right Grant
- 2000-06-29 CZ CZ20014636A patent/CZ303010B6/cs not_active IP Right Cessation
- 2000-06-29 DE DE60004052T patent/DE60004052T2/de not_active Expired - Lifetime
- 2000-06-29 CA CA002378469A patent/CA2378469C/en not_active Expired - Lifetime
- 2000-06-29 BR BRPI0011867A patent/BRPI0011867B8/pt unknown
- 2000-06-30 FR FR0008472A patent/FR2797587A1/fr not_active Withdrawn
-
2001
- 2001-11-29 IL IL146807A patent/IL146807A/en active IP Right Grant
- 2001-11-29 ZA ZA200109868A patent/ZA200109868B/xx unknown
- 2001-12-18 NO NO20016203A patent/NO330260B1/no not_active IP Right Cessation
- 2001-12-20 BG BG106251A patent/BG65364B1/bg unknown
-
2002
- 2002-01-29 HR HR20020088A patent/HRP20020088B1/xx not_active IP Right Cessation
- 2002-08-20 US US10/223,298 patent/US6797732B2/en not_active Expired - Lifetime
- 2002-11-29 HK HK02108609.4A patent/HK1047040B/zh not_active IP Right Cessation
-
2008
- 2008-03-12 JP JP2008063280A patent/JP4885896B2/ja not_active Expired - Lifetime
-
2011
- 2011-01-19 NO NO20110090A patent/NO20110090L/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI991485A (sv) | Ny farmaceutisk komposition | |
NO20015175D0 (no) | Farmasöytisk sammensetning | |
NO20025450L (no) | Ny farmasöytisk sammensetning | |
NO20021116D0 (no) | Ny sammensetning | |
ID27415A (id) | Komposisi farmaseutik | |
PT1242087E (pt) | Composicoes farmaceuticas | |
NO20012915L (no) | Ny farmasöytisk formulering | |
IS5046A (is) | Lyfjasamsetningar | |
DK1524266T3 (da) | Farmaceutisk sammensætning | |
NO20005913L (no) | Legemiddelsammensetning | |
FR2775596B1 (fr) | Nouvelles compositions pharmaceutiques | |
NO20021115L (no) | Ny sammensetning | |
ID29262A (id) | Komposisi farmasi | |
ID27201A (id) | Komposisi farmasi | |
NO20022606L (no) | Farmasöytiske kombinasjoner | |
DE69943245D1 (de) | Gaserzeugende zusammensetzung | |
PT1239832E (pt) | Composicoes farmaceuticas | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
FI4488U1 (sv) | Farmaceutisk komposition | |
DE60020682D1 (de) | Resorcinenthaltende zusammensetzung | |
FR2779145B1 (fr) | Nouvelles compositions pharmaceutiques | |
ID26215A (id) | Komposisi farmasi | |
NO20004816D0 (no) | Ny farmasøytisk formulering | |
ID27329A (id) | Komposisi penghambat | |
NO20022845D0 (no) | Limsammensetning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: ORION CORPORATION Free format text: ORION CORPORATION |
|
MA | Patent expired |